MAKING GREAT DRUGS BETTER

News

Re-Vana Therapeutics Secure Innovate UK Grant

Re-Vana has developed a novel disruptive photocrosslinked proprietary biodegradable sustained release drug delivery implant, EyeLief. The implant will provide significant clinical benefits over current monthly intravitreal injections. Following injection into the eye,...

read more
Re-Vana: Vision In The Future